Despite the implications of CerS5 in CRC, global knockout of CerS5 exacerbated pathology scores and inflammation in mice with DSS-induced colitis, and increased tumor burden in AOM/DSS mice [13]. This evidence concerns the gene CERS5 and colorectal carcinoma.